Sugi Predict

Sugi Predict / Compounds / SCHEMBL17865784

SCHEMBL17865784

SCHEMBL17865784

CC(NC(=O)c1ccc(C(=O)NC(C)C2CCCCC2)cc1)C1CCCCC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 2/20 0.57
▸ CA12 O43570 2/20 0.57
▸ CA1 P00915 2/20 0.57
▸ CA2 P00918 2/20 0.57
▸ MMP2 P08253 2/20 0.57
▸ CA9 Q16790 2/20 0.57
▸ HPGD P15428 3/20 0.55
▸ SMN1; SMN2 Q16637 3/20 0.55
▸ NPC1 O15118 2/20 0.55
▸ RAB9A P51151 2/20 0.55
▸ SMYD3 Q9H7B4 2/20 0.54
▸ NAMPT P43490 2/20 0.52
▸ CYP1A2 P05177 2/20 0.52
▸ CYP2C19 P33261 2/20 0.52
▸ KDM4E B2RXH2 1/20 0.52
▸ ALDH1A1 P00352 1/20 0.52
▸ CYP3A4 P08684 1/20 0.52
▸ CYP2D6 P10635 1/20 0.52
▸ CYP2C9 P11712 1/20 0.52
▸ TAS1R3 Q7RTX0 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23130344 0.92 IDO1 (0.58) CNR2SMN1; SMN2CYP2C19CYP2C9TAS1R3
SCHEMBL27666303 0.92 TAS1R3 (0.55) CNR2CA12CA1CA2MMP2
SCHEMBL27666301 0.92 TAS1R3 (0.55) CNR2CA12CA1CA2MMP2
SCHEMBL29373343 0.89 CNR2 (0.50) CNR2CA12CA1CA2MMP2
SCHEMBL2909362 0.89 CA12 (0.57) CNR2CA12CA1CA2MMP2
SCHEMBL2369222 0.88 MCHR1 (0.51) CNR2CA12CA1CA2MMP2
SCHEMBL506794 0.88 MCHR1 (0.51) CNR2CA12CA1CA2MMP2
SCHEMBL506793 0.88 MCHR1 (0.51) CNR2CA12CA1CA2MMP2
SCHEMBL9989282 0.84 HDAC1 (0.51) CNR2CA12CA1CA2MMP2
SCHEMBL7453238 0.84 HDAC1 (0.51) CNR2CA12CA1CA2MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3475085-B1 MULTILAYER FILMS AND PACKAGES FORMED FROM SAME DOW GLOBAL TECHNOLOGIES LLC (US) 2023-07-05 — — EP disclosed
EP-3237521-B1 POLYETHYLENE COMPOSITIONS WITH IMPROVED OPTICAL PROPERTIES DOW GLOBAL TECHNOLOGIES LLC (US) 2021-01-27 — — EP disclosed
US-10316168-B2 Polyethylene compositions with improved optical properties DOW GLOBAL TECHNOLOGIES LLC (US) 2019-06-11 — — US disclosed
US-20190118516-A1 MULTILAYER FILMS AND PACKAGES FORMED FROM SAME DOW GLOBAL TECHNOLOGIES LLC (US) 2019-04-25 — — US disclosed
US-20180022894-A1 POLYETHYLENE COMPOSITIONS WITH IMPROVED OPTICAL PROPERTIES DOW GLOBAL TECHNOLOGIES LLC (US) 2018-01-25 — — US disclosed
EP-3260295-A1 MULTILAYER FILMS AND PACKAGES FORMED FROM SAME Dow Global Technologies LLC (US) 2017-12-27 — — EP disclosed
EP-3037466-A1 Polyethylene compositions with improved optical properties Dow Global Technologies LLC (US) 2016-06-29 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180022894-A1 POLYETHYLENE COMPOSITIONS WITH IMPROVED OPTICAL PROPERTIES PARG, PARN, FHIT CNR2 2223/4885CA12 3383/4885CA1 4290/4885
US-10316168-B2 Polyethylene compositions with improved optical properties PARG, PARN, FHIT CNR2 2223/4885CA12 3383/4885CA1 4290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.